Metabolic Syndrome: Criteria, Mechanisms and Functional Considerations

In 1988, the endocrinologist Gerald Reaven used a prestigious lecture to describe what he called syndrome X: a cluster of insulin resistance, raised glucose, raised triglycerides, low HDL cholesterol and hypertension that seemed to travel together and to increase cardiovascular risk. The observation was not entirely new, but Reaven’s framing, placing insulin resistance at the centre, was influential. Over the following decades, several organisations produced criteria for what became known as metabolic syndrome, the concept was debated vigorously, and it became one of the most widely used ideas in preventive medicine.

The criteria

In 2009, several international bodies agreed harmonised criteria. Metabolic syndrome is present when a person has at least 3 of the following 5 features.

Because each component is common and the thresholds are modest, metabolic syndrome is widespread, affecting a substantial proportion of adults in many countries, with prevalence rising with age and body weight.

The debate

In 2005, a joint statement from American and European diabetes associations questioned whether metabolic syndrome should be considered a syndrome at all. Their concerns included that the criteria were arbitrary, that the risk associated with the syndrome was no greater than the sum of its parts, that its underlying cause was uncertain, and that treating it did not differ from treating each component. Some argued that established risk calculators predicted cardiovascular disease better.

These criticisms have merit. For predicting cardiovascular risk precisely, validated risk calculators that include age, sex, smoking, cholesterol and blood pressure are generally superior. Metabolic syndrome is not a disease in itself and is not a substitute for a full risk assessment.

But the concept retains practical value. It signals that several risk factors share common mechanisms, that the person is at substantially increased risk of type 2 diabetes, and that interventions addressing those shared mechanisms, particularly weight, diet, activity and sleep, will improve several problems at once.

Shared mechanisms

• Visceral and ectopic fat. Fat stored in the abdomen and in organs such as the liver and pancreas is metabolically active, releasing fatty acids and inflammatory signals that impair insulin action.
• Insulin resistance. Reduced insulin sensitivity in liver, muscle and fat drives raised glucose and triglycerides, while insulin’s effects on the kidney and sympathetic nervous system contribute to hypertension.
• Atherogenic dyslipidaemia. The liver produces more triglyceride rich particles, HDL falls and LDL particles become smaller and more numerous.
• Chronic low grade inflammation. Linking adipose tissue dysfunction to vascular and metabolic damage.
• Lifestyle drivers. Energy excess, refined carbohydrate, inactivity, short sleep, chronic stress and alcohol.
• Genetic and developmental factors, including ancestry and early life nutrition.

Beyond the 5 components

The formal criteria leave out several conditions that share the same mechanisms and are clinically important to look for.

A functional assessment

In practice, recognising metabolic syndrome is the beginning of assessment, not the end. A functional approach asks:

1. When did the components appear, and what happened around that time? Weight gain after a job change, pregnancy, injury or a new medicine is common.
2. Which mediators are active: diet, activity, sleep, stress, alcohol, medicines?
3. Are associated conditions present: fatty liver, sleep apnoea, polycystic ovary syndrome, raised uric acid?
4. What is the patient’s overall cardiovascular risk, using a validated calculator?
5. What does the patient want to change, and what is realistic?

Treatment: shared levers first

The first line approach to metabolic syndrome targets the shared mechanisms.

• Weight reduction of even 5 to 10 percent improves every component in many people.
• Dietary pattern: reduced refined carbohydrate and sugar sweetened drinks, higher fibre, Mediterranean or DASH style patterns, reduced alcohol.
• Physical activity: both aerobic and resistance exercise improve insulin sensitivity, triglycerides and blood pressure.
• Sleep: improving duration and treating sleep apnoea.
• Stress management where it drives eating, sleep or alcohol patterns.

Each component also needs appropriate medical management where indicated: blood pressure and lipid treatment to reduce cardiovascular risk, and glucose monitoring. These are not alternatives to lifestyle intervention, but complements to it.

An illustrative case

A 47 year old engineer is told he has metabolic syndrome after a routine check: waist 104 cm, triglycerides 2.4 mmol/L, HDL 0.9 mmol/L, blood pressure 138/88 mmHg and fasting glucose 5.9 mmol/L. His timeline shows 12 kg of weight gain since starting a desk job with long hours, a diet heavy in refined carbohydrate and takeaway food, 5 hours of sleep and daily beer. His partner reports loud snoring.

His assessment adds a raised ALT, suggesting fatty liver, and a high risk sleep apnoea screen. A sleep study confirms moderate sleep apnoea, which is treated. His plan focuses on meal preparation for work, replacing sugary drinks and reducing beer, a daily walk and 2 strength sessions a week. His doctor calculates his cardiovascular risk and discusses treatment. At 6 months he has lost 7 kg, his triglycerides and blood pressure have improved, his glucose has normalised and his liver tests are better. One set of mechanisms had produced several problems; addressing them improved all of them.

A useful signal

Whether metabolic syndrome is a true syndrome matters less in practice than what it signals: shared mechanisms, rising risk and a set of interventions that address several problems at once. Used as a prompt for comprehensive assessment and coordinated action, it remains one of the most practical concepts in metabolic medicine.